Strength and specificity of different gene promoters in oral cancer cells

Oral Oncology

Volumn 36, Issue 2, 2000, Pages 214-220

  Shillitoe, E J ^a   Noonan, S ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Gene promoter; Gene therapy; Oral cancer

Indexed keywords

ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOUSE MAMMARY TUMOR ONCOVIRUS; MOUTH CANCER; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; VIRUS; WART VIRUS;

GENE EXPRESSION; GENE THERAPY; GENES, P53; GENES, REPORTER; GENETIC VECTORS; HUMANS; MOUTH NEOPLASMS; MUTATION; PHENOTYPE; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED;

EID: 0034163475     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00064-0     Document Type: Article

References (32)

1. Vile R.G., Hart I.R. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Research. 53:1993;962-967.
2. Morelli A.E., Larregina A.T., Smith-Arica J., Dewey R.A., Southgate T.D., Ambar B.et al. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity. Journal of General Virology. 80:1999;571-583.
3. Gao Z., Fields J.Z., Boman B.M. Tumor-specific expression of anti-mdr1 ribozyme selectively restores chemosensitivity in multidrug resistant colon-adenocarcinoma cells. International Journal of Cancer. 82:1999;346-352.
4. Chen Z., Storthz K.A., Shillitoe E.J. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Research. 57:1997;1614-1619.
5. Lee F., Mulligan R., Berg P., Ringold G. Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimeric plasmids. Nature. 294:1981;228-232.
6. Steele C., Sacks P.G., Adler-Storthz K., Shillitoe E.J. Effects on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18. Cancer Research. 52:1992;4706-4711.
7. Nakagawa H., Inomoto T., Rustgi A.K. A CACCC box-like cis-regulatory element of the Epstein-Barr virus ED-L2 promoter interacts with a novel transcriptional factor in tissue-specific squamous epithelia. Journal of Biological Chemistry. 272:1997;16688-16699.
8. Chin K.V., Ueda K., Pastan I., Gottesman M.M. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science. 255:1992;462.
9. Trapnell B.C. Adenoviral vectors for gene transfer. Advances in Drug Delivery Reviews. 12:1993;185-199.
10. Yei S., Mittereder N., Wert S., Whitsett J.A., Wilmott R.W., Trapnell B.C. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Human Gene Therapy. 5:1994;731-744.
11. Marini F.C., Cannon J.P., Belmont J.W., Shillitoe E.J., Lapeyre J.N. In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEK. Human Gene Therapy. 6:1995;1215-1223.
12. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods. 89:1986;271-277.
13. Carmichael J., Mitchell J.B., DeGraff W.G., Gamson J., Gazdar A.F., Johnson B.E.et al. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. British Journal of Cancer. 57:1988;540-547.
14. Yuh C.H., Boloure H., Davidson E.H. Genomic cis-regulatory logic: experimental and computational analysis of a sea urchin gene. Science. 279:1998;1896-1902.
15. Shillitoe E.J., Gilchrist E., Pellenz C., Murrah V. Effects of herpes simplex virus on human oral cancer cells, and potential use of mutant viruses in therapy of oral cancer. Oral Oncology. 35:1999;326-332.
16. Boshart M., Weber F., Jahn G., Dorsch-Hasler K., Fleckenstein B., Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 41:1985;521-530.
17. Gibson SA, Pellenz C, Hutchison RE, Davey F, Shillitoe EJ. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector. [submitted]
18. Feng M., Cabrera G., Deshane J., Scanlon K.J., Curiel D.T. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Research. 55:1995;2024-2028.
19. Chen Z., Kamath P., Zhang S., St John L., Adler-Storthz K., Shillitoe E.J. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18. Cancer Gene Therapy. 3:1996;18-23.
20. Lee G., Hong H.J., You Y.O., Bang E.H., Kook J.K., Min B.M. Effect of p53 gene transfer on the cell proliferation and cell cycle progression in a human oral cancer cell line with p53 mutations. International Journal of Oral Biology. 23:1998;189-199.
21. Xing Z., Whitton J.L. An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield. Journal of Virology. 67:1993;1840-1847.
22. Walther W., Wendt J., Stein U. Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy. Gene Therapy. 4:1997;544-552.
23. Nguyen K.T., Liu B., Ueda K., Gottesman M.M., Pastan I., Chin K.V. Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants. Oncology Research. 6:1994;71-77.
24. Kim M.S., Shin K.H., Baek J.H., Cherick H.M., Park N.H. HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N′-nitro-nitrosoguanidine in oral carcinogenesis. Cancer Research. 53:1993;4811-4816.
25. Woods K.V., Adler-Storthz K., Clayman G.L., Francis G.M., Grimm E.A. Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7. Cancer Research. 58:1998;3142-3149.
26. Stein U., Walther W., Wunderlich V. Point mutations in the mdr1 promoter region of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. European Journal of Cancer. 30:1994;1541-1545.
27. Thompson E.M., Nagata S., Tsuji F.I. Vargula hilgendorfii luciferase: a secreted reporter enzyme for monitoring gene expression in mammalian cells. Gene. 96:1990;257-262.
28. Glazenburg K.L., Peeters B.P.H., Pol J.M.A., Gielkens A.L.J., Moormann R.J.M. Construction and properties of pseudorabies virus recombinants with altered control of immediate-early gene expression. Journal of Virology. 69:1995;189-197.
29. Leask A., Rosenberg M., Vassar R., Fuchs E. Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes and Development. 4:1990;1985-1998.
30. Liu J.J., Kao W.W., Wilson S.E. Corneal epithelium-specific mouse keratin K12 promoter. Experimental Eye Research. 68:1999;295-301.
31. Flotte T.R., Solow R., Owens R.A., Afione S., Zeitlin P.L., Carter B.J. Gene expression from adeno-associated virus vectors in airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology. 7:1992;349-356.
32. Shillitoe E.J., Lapeyre J.N., Adler-Storthz K. Gene therapyits potential in the management of oral cancer. Oral Oncology. 30B:1994;143-154.